HomeCompareDKSHF vs EQR

DKSHF vs EQR: Dividend Comparison 2026

DKSHF yields 3.81% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DKSHF wins by $6.4K in total portfolio value· pulled ahead in Year 6
10 years
DKSHF
DKSHF
● Live price
3.81%
Share price
$70.01
Annual div
$2.67
5Y div CAGR
23.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$46.8K
Annual income
$6,460.93
Full DKSHF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — DKSHF vs EQR

📍 DKSHF pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDKSHFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DKSHF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DKSHF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DKSHF
Annual income on $10K today (after 15% tax)
$324.19/yr
After 10yr DRIP, annual income (after tax)
$5,491.79/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, DKSHF beats the other by $2,245.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DKSHF + EQR for your $10,000?

DKSHF: 50%EQR: 50%
100% EQR50/50100% DKSHF
Portfolio after 10yr
$43.6K
Annual income
$5,140.27/yr
Blended yield
11.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

DKSHF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
5.8
Piotroski
7/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DKSHF buys
0
EQR buys
0
No recent congressional trades found for DKSHF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDKSHFEQR
Forward yield3.81%4.73%
Annual dividend / share$2.67$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR23.5%15.8%
Portfolio after 10y$46.8K$40.5K
Annual income after 10y$6,460.93$3,819.61
Total dividends collected$22.9K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: DKSHF vs EQR ($10,000, DRIP)

YearDKSHF PortfolioDKSHF Income/yrEQR PortfolioEQR Income/yrGap
1$11,171$471.02$11,248$547.57$77.00EQR
2$12,560$607.32$12,701$666.53$141.00EQR
3$14,228$788.15$14,405$814.59$177.00EQR
4$16,254$1,030.45$16,413$999.84$159.00EQR
5$18,751$1,358.75$18,795$1,232.92$44.00EQR
6← crossover$21,872$1,809.15$21,639$1,527.95+$233.00DKSHF
7$25,839$2,435.77$25,057$1,903.80+$782.00DKSHF
8$30,969$3,321.26$29,197$2,385.87+$1.8KDKSHF
9$37,731$4,594.49$34,250$3,008.70+$3.5KDKSHF
10$46,834$6,460.93$40,467$3,819.61+$6.4KDKSHF

DKSHF vs EQR: Complete Analysis 2026

DKSHFStock

DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, marketing, sales, distribution, and after-sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for ethical pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and fashion and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.

Full DKSHF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this DKSHF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DKSHF vs SCHDDKSHF vs JEPIDKSHF vs ODKSHF vs KODKSHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.